Company intelligence / Profile preview

Altogen Labs

Ownership: Private
Development stage: Commercial

Overview

Altogen Labs is a GLP-compliant contract research organization specializing in preclinical pharmacology and biotechnology services. It offers validated xenograft models, safety/toxicology studies for IND applications, stable cell line development, RNAi gene silencing services, compound efficacy testing, liposome encapsulation/delivery technologies, biodistribution studies, cryopreservation/cell banking services. The company serves pharmaceutical/biotech companies and academic institutions worldwide.

Modalities: Small moleculeRNAi-based therapyLiposome-based delivery therapymRNA-based drugsProtein (for encapsulation and delivery)Plasmid DNA (for transfection and gene expression studies)siRNA, shRNA, antisense oligonucleotide (as part of RNAi services)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Altogen Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altogen Labs.

Explore the full profile